A plant-based mutant huntingtin model-driven discovery of impaired expression of GTPCH and DHFR

[1]  S. Makpol,et al.  Epigenetic Changes and Its Intervention in Age-Related Neurodegenerative Diseases , 2020, Cellular and Molecular Neurobiology.

[2]  Gurrein K. Madan,et al.  Genome-wide In Vivo CNS Screening Identifies Genes that Modify CNS Neuronal Survival and mHTT Toxicity , 2020, Neuron.

[3]  F. Calon,et al.  Tetrahydrobiopterin administration facilitates amphetamine-induced dopamine release and motivation in mice , 2019, Behavioural Brain Research.

[4]  J. Moscat,et al.  The complexity of the serine glycine one-carbon pathway in cancer , 2019, The Journal of cell biology.

[5]  L. Ellerby,et al.  Modeling Polyglutamine Expansion Diseases with Induced Pluripotent Stem Cells , 2019, Neurotherapeutics.

[6]  Jane S. Paulsen,et al.  CAG Repeat Not Polyglutamine Length Determines Timing of Huntington’s Disease Onset , 2019, Cell.

[7]  T. Bottiglieri,et al.  Metabolomic analyses of vigabatrin (VGB)-treated mice: GABA-transaminase inhibition significantly alters amino acid profiles in murine neural and non-neural tissues , 2019, Neurochemistry International.

[8]  Ya-ping Tang,et al.  A novel GTPCH deficiency mouse model exhibiting tetrahydrobiopterin-related metabolic disturbance and infancy-onset motor impairments. , 2019, Metabolism: clinical and experimental.

[9]  Jesús Ávila,et al.  Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer’s disease , 2019, Nature Medicine.

[10]  X. W. Yang,et al.  Molecular insights into cortico-striatal miscommunications in Huntington's disease , 2018, Current Opinion in Neurobiology.

[11]  Martin H. Schaefer,et al.  Spatiotemporal Proteomic Profiling of Huntington’s Disease Inclusions Reveals Widespread Loss of Protein Function , 2017, Cell reports.

[12]  Enrico Amico,et al.  Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study. , 2017, The Lancet. Neurology.

[13]  Zhou Du,et al.  agriGO v2.0: a GO analysis toolkit for the agricultural community, 2017 update , 2017, Nucleic Acids Res..

[14]  O. Maddocks,et al.  One-carbon metabolism in cancer , 2017, British Journal of Cancer.

[15]  F. Rébeillé,et al.  Folates in Plants: Research Advances and Progress in Crop Biofortification , 2017, Front. Chem..

[16]  R. Schiffmann,et al.  Tetrahydrobiopterin deficiency in the pathogenesis of Fabry disease , 2017, Human molecular genetics.

[17]  J. Pennings,et al.  Metabolic profiling of presymptomatic Huntington’s disease sheep reveals novel biomarkers , 2017, Scientific Reports.

[18]  Joshua D Rabinowitz,et al.  One-Carbon Metabolism in Health and Disease. , 2017, Cell metabolism.

[19]  George V. Rebec,et al.  Dysregulation of Corticostriatal Connectivity in Huntington’s Disease: A Role for Dopamine Modulation , 2016, Journal of Huntington's disease.

[20]  Yujin E. Kim,et al.  Soluble Oligomers of PolyQ-Expanded Huntingtin Target a Multiplicity of Key Cellular Factors. , 2016, Molecular cell.

[21]  E. Thomas,et al.  DNA methylation in Huntington’s disease: Implications for transgenerational effects , 2016, Neuroscience Letters.

[22]  J. Canales,et al.  Trace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical Implications , 2016, Front. Neurosci..

[23]  K. Vissenberg,et al.  Cell Fate Determination and the Switch from Diffuse Growth to Planar Polarity in Arabidopsis Root Epidermal Cells , 2015, Front. Plant Sci..

[24]  R. Taliyan,et al.  Transcriptional dysregulation in Huntington's disease: The role of histone deacetylases. , 2015, Pharmacological research.

[25]  Shihua Li,et al.  Transgenic animal models for study of the pathogenesis of Huntington’s disease and therapy , 2015, Drug design, development and therapy.

[26]  Wei Wang,et al.  Mutant Huntingtin Downregulates Myelin Regulatory Factor-Mediated Myelin Gene Expression and Affects Mature Oligodendrocytes , 2015, Neuron.

[27]  Yu Xue,et al.  HemI: A Toolkit for Illustrating Heatmaps , 2014, PloS one.

[28]  M. Sakurai,et al.  Disturbed biopterin and folate metabolism in the Qdpr‐deficient mouse , 2014, FEBS letters.

[29]  A. Singleton,et al.  Parkinson’s disease in GTP cyclohydrolase 1 mutation carriers , 2014, Brain : a journal of neurology.

[30]  N. Kowall,et al.  Nucleolar dysfunction in Huntington's disease. , 2014, Biochimica et biophysica acta.

[31]  Jiahua Xie,et al.  Molecular genetics of alkaloid biosynthesis in Nicotiana tabacum. , 2013, Phytochemistry.

[32]  M. Hayden,et al.  Choosing an animal model for the study of Huntington's disease , 2013, Nature Reviews Neuroscience.

[33]  M. Kellogg,et al.  Improved separation and analysis of plasma amino acids by modification of the MassTrak™ AAA Solution Ultraperformance® liquid chromatography method. , 2013, Clinica chimica acta; international journal of clinical chemistry.

[34]  G. Kapatos.  The neurobiology of tetrahydrobiopterin biosynthesis: A model for regulation of GTP cyclohydrolase I gene transcription within nigrostriatal dopamine neurons , 2013, IUBMB life.

[35]  E. Lyon,et al.  Triplet repeat primed PCR simplifies testing for Huntington disease. , 2013, The Journal of molecular diagnostics : JMD.

[36]  Natalia Mendelev,et al.  Selenium preserves mitochondrial function, stimulates mitochondrial biogenesis, and reduces infarct volume after focal cerebral ischemia , 2012, BMC Neuroscience.

[37]  D. Gomez-Casati,et al.  Research on Plants for the Understanding of Diseases of Nuclear and Mitochondrial Origin , 2012, Journal of biomedicine & biotechnology.

[38]  L. Raymond,et al.  Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function , 2011, Neuroscience.

[39]  P. Clayton,et al.  The monoamine neurotransmitter disorders: an expanding range of neurological syndromes , 2011, The Lancet Neurology.

[40]  F. Brandizzi,et al.  Arabidopsis RHD3 mediates the generation of the tubular ER network and is required for Golgi distribution and motility in plant cells , 2011, Journal of Cell Science.

[41]  A. Durr,et al.  Validation of plasma branched chain amino acids as biomarkers in Huntington disease. , 2011, Archives of neurology.

[42]  M. Zielińska,et al.  Hyperammonemia increases the expression and activity of the glutamine/arginine transporter y+LAT2 in rat cerebral cortex: Implications for the nitric oxide/cGMP pathway , 2011, Neurochemistry International.

[43]  M. Aschner,et al.  Roles of glutamine in neurotransmission. , 2010, Neuron glia biology.

[44]  Jianlin Cheng,et al.  Root hair systems biology. , 2010, Trends in plant science.

[45]  F. Coppedè.  One-Carbon Metabolism and Alzheimer’s Disease: Focus on Epigenetics , 2010, Current genomics.

[46]  František Baluška,et al.  Recent surprising similarities between plant cells and neurons , 2010, Plant signaling & behavior.

[47]  Yoko Shibata,et al.  A Class of Dynamin-like GTPases Involved in the Generation of the Tubular ER Network , 2009, Cell.

[48]  C. Hung,et al.  Overexpression of human erythropoietin in tobacco does not affect plant fertility or morphology , 2009, Plant Biotechnology Reports.

[49]  Guoyao Wu,et al.  Amino acids: metabolism, functions, and nutrition , 2009, Amino Acids.

[50]  A. B. Knott,et al.  Mutant huntingtin and mitochondrial dysfunction , 2008, Trends in Neurosciences.

[51]  H. Westerhoff,et al.  Increased glucose metabolism and ATP level in brain tissue of Huntington’s disease transgenic mice , 2008, The FEBS Journal.

[52]  N. Bhattacharyya,et al.  HYPK, a Huntingtin interacting protein, reduces aggregates and apoptosis induced by N-terminal Huntingtin with 40 glutamines in Neuro2a cells and exhibits chaperone-like activity. , 2008, Human molecular genetics.

[53]  Alexandra Durr,et al.  Early Energy Deficit in Huntington Disease: Identification of a Plasma Biomarker Traceable during Disease Progression , 2007, PloS one.

[54]  B. Forde,et al.  Glutamate in plants: metabolism, regulation, and signalling. , 2007, Journal of experimental botany.

[55]  D. Fekkes,et al.  Quantitation of total biopterin and tetrahydrobiopterin in plasma. , 2007, Clinical biochemistry.

[56]  Stefano Mancuso,et al.  Plant neurobiology: an integrated view of plant signaling. , 2006, Trends in plant science.

[57]  N. Jareborg,et al.  Human QKI, a potential regulator of mRNA expression of human oligodendrocyte-related genes involved in schizophrenia. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[58]  B. Harper.  Huntington Disease , 2005, Journal of the Royal Society of Medicine.

[59]  K. Fischbeck,et al.  Therapeutics development for triplet repeat expansion diseases , 2005, Nature Reviews Genetics.

[60]  G. Bates,et al.  Huntingtin and the molecular pathogenesis of Huntington's disease , 2004, EMBO reports.

[61]  Steven M. Hersch,et al.  Translating therapies for Huntington’s disease from genetic animal models to clinical trials , 2004, NeuroRX.

[62]  Mark D. Berry,et al.  Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators , 2004, Journal of neurochemistry.

[63]  D. Guttman.  Plants as models for the study of human pathogenesis. , 2004, Biotechnology advances.

[64]  Rainer Fischer,et al.  Molecular farming in plants: host systems and expression technology. , 2003, Trends in biotechnology.

[65]  A. Bacher,et al.  Folate synthesis in plants: The first step of the pterin branch is mediated by a unique bimodular GTP cyclohydrolase I , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[66]  Y. Shachar-Hill,et al.  Plant one-carbon metabolism and its engineering. , 2000, Trends in plant science.

[67]  Shihua Li,et al.  Aggregation of N-terminal huntingtin is dependent on the length of its glutamine repeats. , 1998, Human molecular genetics.

[68]  Marian DiFiglia,et al.  Huntington Disease , 1998 .

[69]  J. Schiefelbein,et al.  The ROOT HAIR DEFECTIVE3 gene encodes an evolutionarily conserved protein with GTP-binding motifs and is required for regulated cell enlargement in Arabidopsis. , 1997, Genes & development.

[70]  Meizhong Luo,et al.  Molecular cloning and analysis of a cDNA coding for the bifunctional dihydrofolate reductase-thymidylate synthase of Daucus carota , 1993, Plant Molecular Biology.

[71]  Manish S. Shah,et al.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.

[72]  M. Montagu,et al.  Transfection and transformation of Agrobacterium tumefaciens , 1978, Molecular and General Genetics MGG.

[73]  Kelly E. Glajch,et al.  Epigenetic Mechanisms Involved in Huntington's Disease Pathogenesis. , 2015, Journal of Huntington's disease.

[74]  C. Hawes,et al.  An Arabidopsis reticulon and the atlastin homologue RHD3-like2 act together in shaping the tubular endoplasmic reticulum. , 2013, The New phytologist.

[75]  P. Emery.  AMINO ACIDS | Metabolism , 2005 .

[76]  J. Fry,et al.  Leaf disc transformation , 1989 .